Order Article Reprints

Elhazmi A, Rabie AA, Al-Omari A, Mufti HN, Sallam H, Alshahrani MS, Mady A, Alghamdi A, Altalaq A, Azzam MH, et al. Tocilizumab Outcomes in Critically Ill COVID-19 Patients Admitted to the ICU and the Role of Non-Tocilizumab COVID-19-Specific Medical Therapeutics. Journal of Clinical Medicine. 2023; 12(6):2301. https://doi.org/10.3390/jcm12062301

Elhazmi, Alyaa, Ahmed A. Rabie, Awad Al-Omari, Hani N. Mufti, Hend Sallam, Mohammed S. Alshahrani, Ahmed Mady, Adnan Alghamdi, Ali Altalaq, Mohamed H. Azzam, and et al. 2023. "Tocilizumab Outcomes in Critically Ill COVID-19 Patients Admitted to the ICU and the Role of Non-Tocilizumab COVID-19-Specific Medical Therapeutics" Journal of Clinical Medicine 12, no. 6: 2301. https://doi.org/10.3390/jcm12062301

Elhazmi, A., Rabie, A. A., Al-Omari, A., Mufti, H. N., Sallam, H., Alshahrani, M. S., Mady, A., Alghamdi, A., Altalaq, A., Azzam, M. H., Sindi, A., Kharaba, A., Al-Aseri, Z. A., Almekhlafi, G. A., Tashkandi, W., Alajmi, S. A., Faqihi, F., Alharthy, A., Al-Tawfiq, J. A., ... Arabi, Y. M. (2023). Tocilizumab Outcomes in Critically Ill COVID-19 Patients Admitted to the ICU and the Role of Non-Tocilizumab COVID-19-Specific Medical Therapeutics. Journal of Clinical Medicine, 12(6), 2301. https://doi.org/10.3390/jcm12062301